Trans-acting factors regulate the expression of CD44 splice variants

EMBO Journal

Volumn 15, Issue 15, 1996, Pages 4030-4039

  König, Harald ^a   Moll, Jürgen ^a   Ponta, Helmut ^a   Herrlich, Peter ^b  

^a KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

^b UNIVERSITY OF KARLSRUHE   (Germany)

Author keywords

Alternative splicing; CD44 variants; Exon specific PCR; Heterokaryons; trans acting splice factors

Indexed keywords

HERMES ANTIGEN;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; CELL FUSION; CELL NUCLEUS; CONTROLLED STUDY; EXON; FIBROBLAST; GENE EXPRESSION; GENE MUTATION; HETEROKARYON; HUMAN; HUMAN CELL; HYBRID CELL; KERATINOCYTE; METASTASIS; MOUSE; NONHUMAN; PANCREAS CARCINOMA; PRIORITY JOURNAL; RAT; RNA SEQUENCE; RNA SPLICING; UTERINE CERVIX CARCINOMA;

ANIMALIA;

EID: 0029739149     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1460-2075.1996.tb00776.x     Document Type: Article

References (57)

1. Arch, R., Wirth, K., Hofmann, M., Ponta, H., Matzku, S., Herrlich, P. and Zöller, M. (1992). Participation in normal immune responses of a splice variant of CD44 that encodes a metastasis-inducing domain. Science, 257, 682-685.
2. Baron, M.H. and Maniatis, T. (1986) Rapid reprogramming of globin gene expression in transient heterokaryons. Cell, 46, 591-602.
3. Black, D.L. (1991) Does steric interference between splice sites block the splicing of a short c-src neuron-specific exon in non-neuronal cells? Genes Dev., 5, 389-402.
4. Black, D.L. (1992) Activation of c-src neuron-specific splicing by an unusual RNA element in vivo and in vitro. Cell, 69, 795-807.
5. Blau, H.M., Chiu, C.-P. and Webster, C. (1983) Cytoplasmic activation of human nuclear genes in stable heterokaryons. Cell, 32, 1171-1180.
6. Boukamp, P., Petrussevska, R.T., Breitkreutz, D., Hornung, J., Markham, A. and Fusenig, N.E. (1988) Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell. Biol., 106, 761-771.
7. Chomczynski, P. and Sacchi, N. (1987) Single-step method of RNA isolation by acidic guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159.
8. Cooper, T.A. (1992) In vitro splicing of cardiac troponin T precursors. Exon mutations disrupt splicing of the upstream intron. J. Biol. Chem., 267, 5330-5338.
9. Cote, G.J., Stolow, D.T., Peleg, S., Berget, S.M. and Gagel, R.F. (1992) Identification of exon sequences and an exon binding protein involved in alternative RNA splicing of calcitonin/CGRP. Nucleic Acids Res., 20, 2361-2366.
10. Davidson, R.L.A. and de la Cruz, F. (1974) Somatic Cell Hybridization. Raven Press, New York.
11. Deans, J.P., Boyd, A.W. and Pilarski, L.M. (1989) Transitions from high to low molecular weight isoforms of CD45 (T200) involve rapid activation of alternative mRNA splicing and slow turnover of surface CD45R. J. Immunol., 143, 1233-1238.
12. Dirksen, W.P., Hampson, R.K., Sun, Q. and Rottman, F.M. (1994) A purine-rich exon sequence enhances splicing of bovine growth hormone pre-mRNA. J. Biol. Chem., 269, 6431-6436.
13. Ephrussi, B. (1972) Hybridization of Somatic Cells. Princeton University Press, Princeton, NJ.
14. Gallego, M.E., Balvay, E.L. and Brody, E. (1992) Cis-acting sequences involved in exon selection in the chicken β-tropomyosin gene. Mol. Cell. Biol., 12, 5415-5425.
15. Graham, I.R., Hamshere, M. and Eperon, I.C. (1992) Alternative splicing of a human α-tropomyosin muscle-specific exon: identification of determining sequences. Mol. Cell. Biol., 12, 3872-3882.
16. Günthert, U. (1993) CD44: a multitude of isoforms with diverse functions. Curr. Top. Microbiol. Immunol., 184, 47-63.
17. Günthert, U., Hofmann, M., Rudy, W., Reber, S., Zöller, M., Haußmann, I., Matzku, S., Wenzel, S., Ponta, H. and Herrlich, P. (1991) A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell, 65, 13-24.
18. Hampson, R.K., La Follette, L. and Rottman, F.M. (1989) Alternative processing of bovine growth hormone mRNA is influenced by downstream exon sequences. Mol. Cell. Biol., 9, 1604-1610.
19. Harlow, E. and Lane, D. (1988) Antibodies. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
20. Haynes, B.F., Liao, H.-X. and Patton, K.L. (1991) The transmembrane hyaluronate receptor (CD44): multiple functions, multiple forms. Cancer Cells, 3, 347-350.
21. Hedley, M.L. and Maniatis, T. (1991) Sex-specific splicing and polyadenylation of dsx pre-mRNA requires a sequence that binds specifically to tra-2 protein in vitro. Cell, 65, 579-586.
22. Heider, K.-H., Hofmann, M., Horst, E., van den Berg, F., Ponta, H., Herrlich, P. and Pals, S.T. (1993) A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J. Cell Biol., 120, 227-233.
23. Hofmann, M., Rudy, W., Zöller, M., Tölg, C., Ponta, H., Herrlich, P. and Günthert, U. (1991) CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res., 51, 5292-5297.
24. Horowitz, D.S. and Krainer, A.R. (1994) Mechanisms for selecting 5′ splice sites in mammalian pre-mRNA splicing. Trends Genet., 10, 100-106.
25. Hoshijima, K., Inoue, K., Higuchi, I., Sakamoto, H. and Shimura, Y. (1991) Control of doublesex alternative splicing by transformer and transformer-2 in Drosophila. Science, 252, 833-836.
26. Koopman, G., Griffioen, A.W., Ponta, H., Herrlich, P., van den Berg, F., Manten-Horst, E. and Pals, S.T. (1993) CD44 splice variants: expression in lymphocytes and in neoplasia. Res. Immunol., 144, 750-754.
27. Lavigueur, A., La Branche, H., Kornblihtt, A.R. and Chabot, B. (1993) A splicing enhancer in the human fibronectin alternate ED1 exon interacts with SR proteins and stimulates U2 snRNP binding. Genes Dev., 1, 2405-2417.
28. Lesley, J., Hyman, R. and Kincade, P.W. (1993) CD44 and its interactions with the extracellular matrix. Adv. Immunol., 54, 271-335.
29. Libri, D., Goux-Pelletan, M., Brody, E. and Fiszman, M.Y. (1990) Exon as well as intron sequences are cis-regulating elements for the mutually exclusive alternative splicing of the beta tropomyosin gene. Mol. Cell. Biol., 10, 5036-5046.
30. Lynch, K.W. and Maniatis, T. (1995) Synergistic interactions between two distinct elements of a regulated splicing enhancer. Genes Dev., 9, 284-293.
31. Mackay, C.R., Terpe, H.-J., Stauder, R., Marston, W.L., Stark, H. and Günthert, U. (1994) Expression and modulation of CD44 isoforms in humans. J. Cell Biol., 124, 71-82.
32. Matzku, S., Komitowski, D., Mildenberger, M. and Zöller, M. (1983) Characterization of BSp73, a spontaneous rat tumour and its in vivo selected variants sharing different metastasizing capacities. Invasion Metastasis, 3, 109-123.
33. Moll, J., Plug, R., Ponta, H. and Herrlich, P. (1996) The privilege of expressing CD44v - used by immune cells, misused by tumour cells. In Zander, A.R. and Ostertag, W. (eds), Gene Technology. NATO ASI Series, Springer-Verlag, Berlin, Vol. H94, pp. 369-379.
34. Moore, M., Query, C. and Sharp, P. (1993) Splicing of precursors to messenger RNAs by the spliceosome. In Gesteland, R.F. and Atkins, J.F. (eds), The RNA World. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 303-357.
35. Nemeroff, M.E., Utans, U., Kramer, A. and Krug, R.M. (1992) Identification of cis-acting intron and exon regions in influenza virus NS1 mRNA that inhibit splicing and cause the formation of aberrantly sedimenting presplicing complexes. Mol. Cell. Biol., 12, 962-970.
36. Neri, A., Welch, D., Kawaguchi, T. and Nicholson, G.L. (1982) Development and biological properties of malignant cell sublines and clones of spontaneously metastasizing rat mammary adenocarcinoma. J. Natl Cancer. Inst., 68, 507-517.
37. Noguchi, P.D. (1991) Use of flow cytometry for DNA analysis. In Coligan, J.E., Kruisbeek, A.M., Margulies, D.H., Shevach, E.M. and Strober, W. (eds), Current Protocols in Immunology. Greene Publishing Associates, New York, Unit 5.7.1-5.7.6.
38. Reed, R. and Maniatis, T. (1986) A role for exon sequences and splice-site proximity in splice site selection. Cell, 46, 681-690.
39. Rio, D.C. (1993) Splicing of pre-mRNA: mechanism, regulation and role in development. Curr. Opin. Genet. Dev., 3, 574-584.
40. Rothstein, D.M., Saito, H., Streuli, M., Schlossman, S.F. and Morimoto, C. (1992) The alternative splicing of the CD45 tyrosine phosphatase is controlled by negative regulatory trans-acting splicing factors. J. Biol. Chem., 267, 7139-7147.
41. Rudy, W., Hofmann, M., Schwartz-Albiez, R., Zöller, M., Heider,K.-H., Ponta, H. and Herrlich, P. (1993) The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior. Cancer Res., 53, 1262-1268.
42. Screaton, G.R., Bell, M.V., Jackson, D.G., Cornelis, F.B., Gerth, U. and Bell, J.I. (1992) Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc. Natl Acad Sci. USA, 89, 12160-12164.
43. Screaton, G.R., Bell, M.V., Bell, J.I. and Jackson, D.G. (1993) The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor. J. Biol. Chem., 268, 12235-12238.
44. Screaton, G.R., Caceres, J.F., Mayeda, A., Bell, M.V., Plebanski, M., Jackson, D.G., Bell, J.I. and Krainer, A.R. (1995) Identification and characterization of three members of the human SR family of pre-mRNA splicing factors. EMBO J., 14, 4336-4349.
45. Sherman, L., Sleeman, J., Herrlich, P. and Ponta, H. (1994) Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression. Curr. Opin. Cell Biol., 6, 726-733.
46. Sherman, L., Sleeman, J., Dall, P., Hekele, A., Moll, J., Ponta, H. and Herrlich, P. (1996) The CD44 proteins in embryonic development and in cancer. Curr. Top. Microbiol. Immunol., 213, 249-269.
47. Siebel, C.W., Fresco, L.D. and Rio, D.C. (1992) The mechanism of somatic inhibition of Drosophila P-element pre-mRNA splicing: multiprotein complexes at an exon pseudo-5′ splice site control U1 snRNP binding. Genes Dev., 6, 1386-1401.
48. Southern, P.J. and Berg, P. (1982) Transformation of mammalian cells to antibiotic resistance with a bacterial gene under the control of the SV40 early region promoter. J. Mol. Appl. Genet., 1, 327-341.
49. Streuli, M. and Saito, H. (1989) Regulation of tissue-specific alternative splicing: exon-specific cis-elements govern the splicing of leukocytes common antigen pre-mRNA. EMBO J., 8, 787-796.
50. Tanaka, K., Watakabe, A. and Shimura, Y. (1994) Polypurine sequences within a downstream exon function as a splicing enhancer. Mol. Cell. Biol., 14, 1347-1354.
51. Tjian, M. and Maniatis, T. (1993) A splicing enhancer complex controls alternative splicing of double sex pre-mRNA. Cell, 74, 105-114.
52. Tolg, C., Hofmann, M., Herrlich, P. and Ponta, H. (1993) Splicing choice from ten variant exons establishes CD44 variability. Nucleic Acids Res., 21, 1225-1229.
53. Underhill, C. (1992) CD44: the hyaluronan receptor. J. Cell Sci., 103, 293-298.
54. van Weering, D.H.J., Baas, P.D. and Bos, J.L. (1993) A PCR based method for the analysis of human CD44 splice products. PCR Methods Applications, 3, 100-106.
55. Watakabe, W., Tanaka, K. and Shimura, Y. (1993) The role of exon sequences in splice site selection. Genes Dev., 7, 407-418.
56. Xu, R., Teng, J. and Cooper, T.A. (1993) The cardiac troponin T alternative exon contains a novel purine-rich positive splicing element. Mol. Cell. Biol., 13, 3660-3674.
57. Zahler, A.M., Lane, W.S., Stolk, J.A. and Roth, M.B. (1992) SR proteins: a conserved family of pre-mRNA splicing factors. Genes Dev., 6, 837-847.